Hutch News

Hutch News

Stories tagged 'skin cancer'

As U.S. cases of skin cancer rise, costs skyrocket, too

Five million American adults are diagnosed each year at a cost of $8.1 billion, new CDC study finds

Nov. 9, 2014 | By JoNel Aleccia / Fred Hutch News Service

Five million American adults are diagnosed each year at a cost of $8.1 billion, new CDC study finds.

View story >


Surgeon general: Stop sunbathing and get out of the tanning bed

New report issues ‘call to action’ in wake of rising skin cancer rates

July 29, 2014 | By JoNel Aleccia / Fred Hutch News Service

New report issues ‘call to action’ in wake of rising skin cancer rates

View story >


Tanning beds get a black label warning

Citing skin cancer risks, new FDA regulations caution against use by teens

May 29, 2014 | By Mary Engel

Indoor tanning beds, booths and sunlamps that emit ultraviolet radiation must now carry a visible black box warning that they should not be used by anyone under age 18 because they increase the risk of skin cancer, according to new regulations issued by the U.S. Food and Drug Administration.

View story >


Tanning beds in the hot seat as skin cancer rates jump

Incidence of melanoma has increased dramatically in last four decades, new study finds

Feb. 5, 2014 | By Diane Mapes

View story >


After beating rare cancer, 'signing up for Obliteride was a no-brainer'

Keith Winkle will come back to Seattle from Alaska to ride because research saved his life; the Aug. 9-11 bike ride will raise funds to benefit Fred Hutchinson Cancer Research Center

May 24, 2013 | By Justin Matlick

When Keith Winkle was getting radiation treatments at Seattle Cancer Care Alliance, he rode his bike 18 miles from his parents' house to each appointment, then rode all the way back—sometimes with a detour around Lake Washington. It's the kind of commitment to beating cancer—and to cycling—that powers Obliteride, the Aug. 9-11 bike ride to raise funds for Hutchinson Center research. Winkle is training for the event's 100-mile segment.

View story >


New squamous cell carcinoma drug target discovered

Vasioukhin and colleagues find alpha-catenin protein acts as a tumor suppressor, cell growth control mechanism revealed

May 30, 2011 | By Kristen Woodward

Hutchinson Center researchers have discovered a new drug target for squamous cell carcinoma, the second most common form of skin cancer. Scientists in the Human Biology Division laboratory of Dr. Valeri Vasioukhin found a protein called alpha-catenin acts as a tumor suppressor and they also have unlocked the mechanism by which this protein controls cell proliferation.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.